Regulation of Medulloblastoma Metastasis by Emp1
Emp1 对髓母细胞瘤转移的调节
基本信息
- 批准号:9896856
- 负责人:
- 金额:$ 42.66万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-03-01 至 2022-02-28
- 项目状态:已结题
- 来源:
- 关键词:AddressAdhesionsAnimal ModelAutomobile DrivingBehaviorBiologyBrainBrain NeoplasmsCell Surface ProteinsCell modelCellsCerebrospinal FluidChemotherapy and/or radiationClinical TrialsDataDiseaseEpithelialEpitheliumExcisionExhibitsFaceGene ExpressionGenesGenomicsGrowthHumanImmunologicsLightMalignant NeoplasmsMalignant neoplasm of brainMalignant neoplasm of lungMediatingMembrane ProteinsMeningesMetastatic Neoplasm to the LeptomeningesMetastatic toMolecularMusNatural regenerationNeoplasm MetastasisOperative Surgical ProceduresPTK2 genePathway interactionsPatient-Focused OutcomesPatientsPediatric NeoplasmPharmacologyPhosphotransferasesPlayPopulationPrimary NeoplasmProliferatingRegimenRegulationReporterRoleSignal TransductionSpinalSpinal CordTestingTherapeuticXenograft procedurecell motilityeffective therapyembryonic stem cellimprovedimproved outcomein vivoinsightkinase inhibitorknock-downleukemia/lymphomamedulloblastomamigrationmouse modelneoplastic cellnovelnovel strategiesnovel therapeuticsoutcome forecastoverexpressionpreventpublic health relevance
项目摘要
DESCRIPTION (provided by applicant): Medulloblastoma (MB) is the most common malignant brain tumor in children. Even with an intensive regimen of surgery, radiation and chemotherapy, 25-30% of MB patients still die from their disease. While the vast majority of MB studies have focused on primary tumors, relatively few have examined the biology of leptomeningeal metastasis (LM), the spread of tumor cells through the meninges to the brain and spinal cord. LM, most commonly seen in patients with MYC-driven MB, is not amenable to surgical resection and is associated with extremely poor patient outcomes. Thus, there is a critical need to understand the molecular mechanisms driving metastasis so that more effective therapies can be developed. Using a mouse model of MYC-driven MB in which tumor cells exhibit LM, we recently found that metastatic tumor cells are more likely than primary tumor cells to regenerate metastatic lesions when injected into the cerebrospinal fluid. To identify pathways that mediate this difference in metastatic potential, we compared gene expression in primary vs. metastatic tumor cells from our animal model as well as from MB patients, and found that the tetraspan membrane protein Epithelial membrane protein 1 (Emp1) is significantly elevated in both murine and human metastases. Emp1 has been implicated in cell motility, adhesion and proliferation in leukemia, lymphoma and lung cancer, but has never been studied in the context of MB. In preliminary studies we found that a large proportion of metastatic cells express Emp1, and that overexpression of Emp1 in primary MB cells increases their metastatic behavior in vivo. These data have led us to hypothesize that Emp1 may function as a marker and a driver of metastasis. We will test this by determining 1) whether Emp1 marks cells with increased metastatic potential and 2) whether Emp1 is required for metastatic dissemination. These studies will provide critical insight into the mechanisms of metastasis in MB and yield novel approaches for treating metastatic disease.
描述(由申请人提供):髓母细胞瘤(MB)是儿童中最常见的恶性脑肿瘤。即使采用手术、放疗和化疗的强化方案,25-30%的MB患者仍然死于他们的疾病。虽然绝大多数MB研究都集中在原发性肿瘤上,但相对较少研究软脑膜转移(LM)的生物学,即肿瘤细胞通过脑膜扩散到大脑和脊髓。LM最常见于MYC驱动的MB患者,不适合手术切除,并且与极差的患者结局相关。因此,迫切需要了解驱动转移的分子机制,以便开发更有效的治疗方法。使用MYC驱动MB的小鼠模型,其中肿瘤细胞表现出LM,我们最近发现,当注射到脑脊液中时,转移性肿瘤细胞比原发性肿瘤细胞更有可能再生转移性病变。为了确定介导这种转移潜力差异的途径,我们比较了来自我们的动物模型以及MB患者的原发性与转移性肿瘤细胞中的基因表达,并发现tetraspan膜蛋白上皮膜蛋白1(Emp 1)在小鼠和人转移瘤中均显著升高。Emp 1与白血病、淋巴瘤和肺癌的细胞运动、粘附和增殖有关,但从未在MB的背景下进行过研究。在初步研究中,我们发现大部分转移性细胞表达Emp 1,并且在原代MB细胞中Emp 1的过表达增加了它们的体内转移行为。这些数据使我们假设Emp 1可能是转移的标志物和驱动因素。我们将通过确定1)Emp 1是否标记具有增加的转移潜能的细胞和2)Emp 1是否是转移性播散所必需的来测试这一点。这些研究将为MB转移机制提供重要见解,并产生治疗转移性疾病的新方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Robert J. Wechsler-Reya其他文献
RETRACTED ARTICLE: Tumor necrosis factor overcomes immune evasion in p53-mutant medulloblastoma
撤回文章:肿瘤坏死因子克服 p53 突变型髓母细胞瘤中的免疫逃避
- DOI:
10.1038/s41593-020-0628-4 - 发表时间:
2020-05-18 - 期刊:
- 影响因子:20.000
- 作者:
Alexandra Garancher;Hiromichi Suzuki;Svasti Haricharan;Lianne Q. Chau;Meher Beigi Masihi;Jessica M. Rusert;Paula S. Norris;Florent Carrette;Megan M. Romero;Sorana A. Morrissy;Patryk Skowron;Florence M. G. Cavalli;Hamza Farooq;Vijay Ramaswamy;Steven J. M. Jones;Richard A. Moore;Andrew J. Mungall;Yussanne Ma;Nina Thiessen;Yisu Li;Alaide Morcavallo;Lin Qi;Mari Kogiso;Yuchen Du;Patricia Baxter;Jacob J. Henderson;John R. Crawford;Michael L. Levy;James M. Olson;Yoon-Jae Cho;Aniruddha J. Deshpande;Xiao-Nan Li;Louis Chesler;Marco A. Marra;Harald Wajant;Oren J. Becher;Linda M. Bradley;Carl F. Ware;Michael D. Taylor;Robert J. Wechsler-Reya - 通讯作者:
Robert J. Wechsler-Reya
Integrated genome and tissue engineering enables screening of cancer vulnerabilities in physiologically relevant perfusable emex vivo/em cultures
整合基因组和组织工程技术能够在生理相关的可灌注体外培养物中筛选癌症的脆弱性
- DOI:
10.1016/j.biomaterials.2021.121276 - 发表时间:
2022-01-01 - 期刊:
- 影响因子:12.900
- 作者:
Michael Hu;Xin Yi Lei;Jon D. Larson;Melissa McAlonis;Kyle Ford;Daniella McDonald;Krystal Mach;Jessica M. Rusert;Robert J. Wechsler-Reya;Prashant Mali - 通讯作者:
Prashant Mali
Single-cell mapping identifies MSIsup+/sup cells as a common origin for diverse subtypes of pancreatic cancer
单细胞图谱确定 MSI+/细胞是胰腺癌不同亚型的共同起源
- DOI:
10.1016/j.ccell.2023.09.008 - 发表时间:
2023-11-13 - 期刊:
- 影响因子:44.500
- 作者:
Nirakar Rajbhandari;Michael Hamilton;Cynthia M. Quintero;L. Paige Ferguson;Raymond Fox;Christian M. Schürch;Jun Wang;Mari Nakamura;Nikki K. Lytle;Matthew McDermott;Emily Diaz;Hannah Pettit;Marcie Kritzik;Haiyong Han;Derek Cridebring;Kwun Wah Wen;Susan Tsai;Michael G. Goggins;Andrew M. Lowy;Robert J. Wechsler-Reya;Tannishtha Reya - 通讯作者:
Tannishtha Reya
The transcription factor LHX2 mediates and enhances oncogenic BMP signaling in medulloblastoma
转录因子 LHX2 介导并增强髓母细胞瘤中的致癌性骨形态发生蛋白信号通路。
- DOI:
10.1038/s41418-025-01488-6 - 发表时间:
2025-03-28 - 期刊:
- 影响因子:15.400
- 作者:
Yae Ohata;Mohamad M. Ali;Yutaro Tsubakihara;Yuka Itoh;Gabriela Rosén;Tobias Bergström;Anita Morén;Irene Golán-Cancela;Ayana Nakada;Oleksandr Voytyuk;Maiko Tsuchiya;Rei Fukui;Kouhei Yamamoto;Paula Martín-Rubio;Patricia Sancho;Carina Strell;Patrick Micke;Robert J. Wechsler-Reya;Yoshinobu Hashizume;Kohei Miyazono;Laia Caja;Carl-Henrik Heldin;Fredrik J. Swartling;Aristidis Moustakas - 通讯作者:
Aristidis Moustakas
Robert J. Wechsler-Reya的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Robert J. Wechsler-Reya', 18)}}的其他基金
Identifying and Targeting the Drivers of Pediatric Brain Tumors
识别并针对儿童脑肿瘤的驱动因素
- 批准号:
10708545 - 财政年份:2022
- 资助金额:
$ 42.66万 - 项目类别:
Identifying and Targeting the Drivers of Pediatric Brain Tumors
识别并针对儿童脑肿瘤的驱动因素
- 批准号:
10397691 - 财政年份:2021
- 资助金额:
$ 42.66万 - 项目类别:
Identifying and Targeting the Drivers of Pediatric Brain Tumors
识别并针对儿童脑肿瘤的驱动因素
- 批准号:
10240154 - 财政年份:2021
- 资助金额:
$ 42.66万 - 项目类别:
Regulation of Medulloblastoma Metastasis by Emp1
Emp1 对髓母细胞瘤转移的调节
- 批准号:
9222061 - 财政年份:2016
- 资助金额:
$ 42.66万 - 项目类别:
Stem Cells, Progenitors, and the Origin of Medulloblastoma
干细胞、祖细胞和髓母细胞瘤的起源
- 批准号:
8244482 - 财政年份:2009
- 资助金额:
$ 42.66万 - 项目类别:
IMAGING OF PRE-NEOPLASTIC LESIONS IN A MOUSE MODEL OF MEDULLOBLASTOMA
髓母细胞瘤小鼠模型中肿瘤前病变的成像
- 批准号:
7956907 - 财政年份:2009
- 资助金额:
$ 42.66万 - 项目类别:
Stem Cells, Progenitors, and the Origin of Medulloblastoma
干细胞、祖细胞和髓母细胞瘤的起源
- 批准号:
7798066 - 财政年份:2009
- 资助金额:
$ 42.66万 - 项目类别:
Identification of a Mitogen for Neuronal Progenitors in the Embryonic Cerebellum
胚胎小脑神经元祖细胞有丝分裂原的鉴定
- 批准号:
7932829 - 财政年份:2009
- 资助金额:
$ 42.66万 - 项目类别:
Stem Cells, Progenitors, and the Origin of Medulloblastoma
干细胞、祖细胞和髓母细胞瘤的起源
- 批准号:
8446152 - 财政年份:2009
- 资助金额:
$ 42.66万 - 项目类别:
Stem Cells, Progenitors, and the Origin of Medulloblastoma
干细胞、祖细胞和髓母细胞瘤的起源
- 批准号:
8063052 - 财政年份:2009
- 资助金额:
$ 42.66万 - 项目类别:
相似海外基金
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
- 批准号:
BB/Y004841/1 - 财政年份:2024
- 资助金额:
$ 42.66万 - 项目类别:
Research Grant
Defining a role for non-canonical mTORC1 activity at focal adhesions
定义非典型 mTORC1 活性在粘着斑中的作用
- 批准号:
BB/Y001427/1 - 财政年份:2024
- 资助金额:
$ 42.66万 - 项目类别:
Research Grant
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
- 批准号:
BB/Y005414/1 - 财政年份:2024
- 资助金额:
$ 42.66万 - 项目类别:
Research Grant
Development of a single-use, ready-to-use, sterile, dual chamber, dual syringe sprayable hydrogel to prevent postsurgical cardiac adhesions.
开发一次性、即用型、无菌、双室、双注射器可喷雾水凝胶,以防止术后心脏粘连。
- 批准号:
10669829 - 财政年份:2023
- 资助金额:
$ 42.66万 - 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
- 批准号:
10587090 - 财政年份:2023
- 资助金额:
$ 42.66万 - 项目类别:
Improving Maternal Outcomes of Cesarean Delivery with the Prevention of Postoperative Adhesions
通过预防术后粘连改善剖宫产的产妇结局
- 批准号:
10821599 - 财政年份:2023
- 资助金额:
$ 42.66万 - 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
- 批准号:
10841832 - 财政年份:2023
- 资助金额:
$ 42.66万 - 项目类别:
Prevention of Intraabdominal Adhesions via Release of Novel Anti-Inflammatory from Surface Eroding Polymer Solid Barrier
通过从表面侵蚀聚合物固体屏障中释放新型抗炎剂来预防腹内粘连
- 批准号:
10532480 - 财政年份:2022
- 资助金额:
$ 42.66万 - 项目类别:
I-Corps: A Sprayable Tissue-Binding Hydrogel to Prevent Postsurgical Cardiac Adhesions
I-Corps:一种可喷雾的组织结合水凝胶,可防止术后心脏粘连
- 批准号:
10741261 - 财政年份:2022
- 资助金额:
$ 42.66万 - 项目类别:
Sprayable Polymer Blends for Prevention of Site Specific Surgical Adhesions
用于预防特定部位手术粘连的可喷涂聚合物共混物
- 批准号:
10674894 - 财政年份:2022
- 资助金额:
$ 42.66万 - 项目类别:














{{item.name}}会员




